Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 111 results.
User Information
Export Records
  1. 1.   A robust fluorogenic substrate for chikungunya virus protease (nsP2) activity
  2. Makhaik, Sparsh; Rut, Wioletta; Choudhary, Shruti; Upadhyay, Tulsi; Hao, Chenzhou; Westberg, Michael; Bobst, Cedric; Yoo,Euna; Fejzo, Jasna; Lin, Michael Z; Bogyo, Matthew; Thompson, Paul; Drag, Marcin; Hardy, Jeanne A
  3. Protein Science : a publication of the Protein Society. 2025, Mar; 34(3): e70069.
  1. 2.   Corneal and conjunctival abnormalities in a cohort of survivors from the Western African Ebola virus disease outbreak
  2. Fashina, Tolulope; Nguyen, Nam V; Huang, Ye; Randleman, Casey; Hartley, Caleb D; Mattia, John G; Vandy, Matthew J; Harrison-Williams, Lloyd C; Mustapha, Jalikatu; Mwanza, Jean-Claude; Hayek, Brent R; Crozier,Ian; Shantha, Jessica G; Yeh, Steven
  3. AJO International. 2024, Dec 11; 1(4):
  1. 3.   Multitarget Potential of Phytochemicals from Traditional Medicinal Tree, Terminalia arjuna (Roxb. ex DC.) Wight & Arnot as Potential Medicaments for Cardiovascular Disease: An In-Silico Approach
  2. Kumar, Vikas; Sharma, Nitin; Orfali, Raha; Patel,Chiragkumar; Alnajjar, Radwan; Saini, Rakshandha; Sourirajan, Anuradha; Khosla, Prem Kumar; Dev, Kamal; Perveen, Shagufta
  3. Molecules (Basel, Switzerland). 2023, Jan 20; 28(3):
  1. 4.   Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model
  2. Vezina, Amelie; Manglani, Monica; Morris, DreeAnna; Foster, Brandon; McCord, Matthew; Song, Hua; Zhang, Meili; Davis, Dionne; Zhang, Wei; Bills, Jessica; Nagashima, Kunio; Shankarappa, Priya; Kindrick, Jessica; Walbridge, Stuart; Peer, Cody J.; Figg, William D.; Gilbert, Mark R.; McGavern, Dorian B.; Muldoon, Leslie L.; Jackson, Sadhana
  3. Molecular Cancer Research. 2021, Dec; 19(12): 2081-2095.
  1. 5.   C/EBPd protects from radiation-induced intestinal injury and sepsis by suppression of inflammatory and nitrosative stress
  2. Banerjee, Sudip; Fu, Qiang; Shah, Sumit K; Melnyk, Stepan B; Sterneck,Esta; Hauer-Jensen, Martin; Pawar, Snehalata A
  3. Scientific reports. 2019, Sep 27; 9(1): 13953.
  1. 6.   Genetic deletion of trkB.T1 increases neuromuscular function
  2. Dorsey, S. G.; Lovering, R. M.; Renn, C. L.; Leitch, C. C.; Liu, X. Y.; Tallon, L. J.; Sadzewicz, L. D.; Pratap, A.; Ott, S.; Sengamalay, N.; Jones, K. M.; Barrick, C.; Fulgenzi, G.; Becker, J.; Voelker, K.; Talmadge, R.; Harvey, B. K.; Wyatt, R. M.; Vernon-Pitts, E.; Zhang, C.; Shokat, K.; Fraser-Liggett, C.; Balice-Gordon, R. J.; Tessarollo, L.; Ward, C. W.
  3. American Journal of Physiology-Cell Physiology. 2012, Jan; 302(1): C141-C153.
  1. 7.   Multistrand RNA Secondary Structure Prediction and Nanostructure Design Including Pseudoknots
  2. Bindewald, E.; Afonin, K.; Jaeger, L.; Shapiro, B. A.
  3. Acs Nano. 2011, Dec; 5(12): 9542-9551.
  1. 8.   Normalization of Proliferation and Tight Junction Formation in Bladder Epithelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome by d-Proline and d-Pipecolic Acid Derivatives of Antiproliferative Factor
  2. Keay, S.; Kaczmarek, P.; Zhang, C. O.; Koch, K.; Szekely, Z.; Barchi, J. J.; Michejda, C.
  3. Chemical Biology & Drug Design. 2011, Jun; 77(6): 421-430.
  1. 9.   The Cytoskeletal Adaptor Protein Band 4.1B Is Required for the Maintenance of Paranodal Axoglial Septate Junctions in Myelinated Axons
  2. Buttermore, E. D.; Dupree, J. L.; Cheng, J.; An, X. L.; Tessarollo, L.; Bhat, M. A.
  3. Journal of Neuroscience. 2011, Jun; 31(22): 8013-8024.
  1. 11.   Inhibitors of the Oncogenic Transcription Factor AP-1 from Podocarpus latifolius
  2. Devkota, K. P.; Ratnayake, R.; Colburn, N. H.; Wilson, J. A.; Henrich, C. J.; McMahon, J. B.; Beutler, J. A.
  3. Journal of Natural Products. 2011, Mar; 74(3): 374-377.
  1. 12.   The arylstibonic acid compound NSC13746 disrupts B-ZIP binding to DNA in living cells
  2. Heyerdahl, S. L.; Rozenberg, J.; Jamtgaard, L.; Rishi, V.; Varticovski, L.; Akah, K.; Scudiero, D.; Shoemaker, R. H.; Karpova, T. S.; Day, R. N.; McNally, J. G.; Vinson, C.
  3. European Journal of Cell Biology. 2010, Jul; 89(7): 564-573.
  1. 13.   12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers
  2. Rishi, V.; Oh, W. J.; Heyerdahl, S. L.; Zhao, J. F.; Scudiero, D.; Shoemaker, R. H.; Vinson, C.
  3. Journal of Structural Biology. 2010, May; 170(2): 216-225.
  1. 14.   Temporal characteristics of botulinum neurotoxin therapy
  2. Lebeda, F. J.; Cer, R. Z.; Stephens, R. M.; Mudunuri, U.
  3. Expert Review of Neurotherapeutics. 2010, Jan; 10(1): 93-103.
  1. 15.   A selective small-molecule nuclear factor-kappa B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits"
  2. Kang, M. I.; Henrich, C. J.; Bokesch, H. R.; Gustafson, K. R.; McMahon, J. B.; Baker, A. R.; Young, M. R.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2009 8(3): 571-581.
  1. 16.   EphrinB reverse signaling in cell-cell adhesion: is it just par for the course?
  2. Lee, H. S.; Daar, I. O.
  3. Cell adhesion & migration. 2009 3(3): 250-255.
  1. 17.   JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells
  2. Yin, Y. M.; Wang, S.; Sun, Y. J.; Matt, Y.; Colburn, N. H.; Shu, Y. Q.; Han, X.
  3. Biomedicine and Pharmacotherapy. 2009 63(6): 429-435.
  1. 18.   Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo
  2. Oh, J.; McWilliams, M. J.; Julias, J. G.; Hughes, S. H.
  3. Journal of Virology. 2008 82(2): 719-727.
  1. 19.   Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors
  2. Shen, Q.; Uray, I. P.; Li, Y. X.; Zhang, Y.; Hill, J.; Xu, X. C.; Young, M. R.; Gunther, E. J.; Hilsenbeck, S. G.; Colburn, N. H.; Chodosh, L. A.; Brown, P. H.
  3. Cancer Prevention Research. 2008 1(1): 45-55.
  1. 20.   Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
  2. Wei, Q.; Jiang, H.; Matthews, C. P.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(50): 19738-19743.
  1. 21.   The Need4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch
  2. Oberst, A.; Malatesta, M.; Aqeilan, R. I.; Rossi, M.; Salomoni, P.; Murillas, R.; Sharma, P.; Kuehn, M. R.; Orerill, M.; Croce, C. M.; Bernassola, F.; Melino, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jul; 104(27): 11280-11285.
  1. 22.   AP-1 a target for cancer prevention
  2. Matthews, C. P.; Colburn, N. H.; Young, M. R.
  3. Current Cancer Drug Targets. 2007, Jun; 7(4): 317-324.
  1. 23.   Hairpin- and cruciform-mediated chromosome breakage: causes and consequences in eukaryotic cells
  2. Lobachev, K. S.; Rattray, A.; Narayanan, V.
  3. Frontiers in Bioscience. 2007, May; 12: 4208-4220.
  1. 24.   Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis
  2. Matthews, C. P.; Birkholz, A. M.; Baker, A. R.; Perella, C. M.; Becky, G. R.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2007, Mar; 67(6): 2430-2438.
  1. 25.   Discoidin domain receptor 1 mediates collagen-induced nitric oxide production in J774A.1 murine macrophages
  2. Kim, S. H.; Lee, S.; Suk, K.; Bark, H.; Jun, C. D.; Kim, D. K.; Choi, C. H.; Yoshimura, T.
  3. Free Radical Biology and Medicine. 2007, Feb; 42(3): 343-352.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel